HF/Transplantation

Top Story

Beta-blockers safely benefit patients with PAH

Beta-blockers safely benefit patients with PAH
September 22, 2017

Patients with pulmonary arterial hypertension who were treated with carvedilol had improved outcomes, according to a study published in JCI Insight.

“New therapies for right-sided heart failure and PAH have lagged behind left-sided heart failure, so there is vital need for new treatments,” W. H. Wilson Tang, MD, director of the Center for Clinical Genomics at the Cleveland Clinic, told Cardiology Today. “The fact that beta-blockers were well-tolerated and effective in lowering heart rates thereby improved the heart efficiency is a key observation, since doctors have been cautioned against using them in this setting for safety concerns. This study provided important new data that advances our knowledge of using this class of drugs in this chronic and life-threatening lung-associated vascular disease.”

Right-side heart pump receives FDA premarket approval

September 21, 2017
The FDA announced the premarket approval of a right-side heart pump designed to treat patients with acute HF or decompensation following left ventricular assist device…

2 decades of implantable cardiac devices

September 20, 2017
Twenty years ago is approximately when the first dual-chamber defibrillators were available for use. Up to that point, defibrillators had undergone some advances…
In the Journals Plus

DAAs safe, effective for heart transplant recipients with HCV

September 18, 2017
Direct-acting antiviral therapies Harvoni and Daklinza plus Sovaldi were both safe and highly effective among patients with chronic hepatitis C virus infection who…
More Headlines »
Advertisement
Advertisement